Professor Ian Yang
Professor

Ian Yang

Email: 
Phone: 
+61 7 3139 5050

Background

Professor Ian Yang is a Thoracic Physician and Director of Thoracic Medicine at The Prince Charles Hospital, and Head of the PCH-Northside Clinical Unit, School of Clinical Medicine, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Availability

Professor Ian Yang is:
Available for supervision

Fields of research

Biomedical and Clinical Sciences Cardiovascular medicine and haematology Clinical sciences Oncology and carcinogenesis Respiratory diseases

Qualifications

  • Bachelor (Honours) of Medicine Surgery, The University of Queensland
  • Postgraduate Diploma, University of Newcastle
  • Doctor of Philosophy, The University of Queensland
  • Asian Pacific Society of Respirology, Asian Pacific Society of Respirology
  • Royal Australasian College of Physicians, Royal Australasian College of Physicians
  • The Thoracic Society of Australia and New Zealand, The Thoracic Society of Australia and New Zealand

Research interests

  • Clinical and translational research in chronic lung diseases

    Pathogenesis, diagnosis and treatment of chronic lung diseases, including COPD, asthma, lung cancer, mesothelioma and effects of air pollution

Research impacts

His clinical work is in the field of thoracic medicine, and his research team is studying gene-environmental interaction in COPD, asthma, lung cancer and air pollution. He is involved in the training of higher degree students in translational research into lung diseases.

He is a Chair of the National COPD Guidelines Committee of the Lung Foundation Australia, and a member of the COPD Coordinating Committee. He is Chair of the Medical Programs and Research Advisory Committee of the Asthma Foundation Queensland NSW.

Search Professor Ian Yang’s works on UQ eSpace

366 works between 1999 and 2025
All (366) Journal Article (267) Other Outputs (1) Conference Publication (88) Book Chapter (10)

341 - 360 of 366 works

2005

Journal Article

Association of tumor necrosis factor-alpha polymorphisms and ozone-induced change in lung function

Yang, Ian A., Holz, Olaf, Jorres, Rudolf A., Magnussen, Helgo, Barton, Sheila J., Rodriguez, Santiago, Cakebread, Julie A., Holloway, John W. and Holgate, Stephen T. (2005). Association of tumor necrosis factor-alpha polymorphisms and ozone-induced change in lung function. American Journal of Respiratory and Critical Care Medicine, 171 (2), 171-176. doi: 10.1164/rccm.200402-194OC

Association of tumor necrosis factor-alpha polymorphisms and ozone-induced change in lung function

2004

Journal Article

TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis (vol 170, pg 187, 2003)

Yang, I.A., Holloway, J.W. and Ye, S. (2004). TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis (vol 170, pg 187, 2003). Atherosclerosis, 173 (1), 155-155. doi: 10.1016/j.atherosclerosis.2003.11.001

TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis (vol 170, pg 187, 2003)

2004

Journal Article

Cytokine gene polymorphisms in idiopathic pulmonary fibrosis

Riha, R.L., Yang, I.A., Rabnott, G.C., Tunnicliffe, A.M., Fong, K.M. and Zimmerman, P.V. (2004). Cytokine gene polymorphisms in idiopathic pulmonary fibrosis. Internal Medicine Journal, 34 (3), 126-129. doi: 10.1111/j.1444-0903.2004.00503.x

Cytokine gene polymorphisms in idiopathic pulmonary fibrosis

2004

Journal Article

Toll-like receptor polymorphisms and allergic disease: interpreting the evidence from genetic studies

Yang, IA, Holgate, ST and Holloway, JW (2004). Toll-like receptor polymorphisms and allergic disease: interpreting the evidence from genetic studies. CLINICAL AND EXPERIMENTAL ALLERGY, 34 (2), 163-166. doi: 10.1111/j.1365-2222.2004.01893.x

Toll-like receptor polymorphisms and allergic disease: interpreting the evidence from genetic studies

2004

Journal Article

Toll-like receptor 4 polymorphism and severity of atopy in asthmatics

Yang, IA, Barton, SJ, Rorke, S, Cakebread, JA, Keith, TP, Clough, JB, Holgate, ST and Holloway, JW (2004). Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes And Immunity, 5 (1), 41-45. doi: 10.1038/sj.gene.6364037

Toll-like receptor 4 polymorphism and severity of atopy in asthmatics

2004

Journal Article

Toll-like receptor polymorphisms and allergic disease: interpreting the evidence from genetic studies

Yang, I. A., Holgate, S. T. and Holloway, J. W. (2004). Toll-like receptor polymorphisms and allergic disease: interpreting the evidence from genetic studies. Clinical & Experimental Allergy, 34 (2), 163-166. doi: 10.1111/j.1365-2222.2004.01893.x

Toll-like receptor polymorphisms and allergic disease: interpreting the evidence from genetic studies

2004

Journal Article

Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma

Kedda, MA, Shi, J, Duffy, D, Phelps, S, Yang, I, O'Hara, K, Fong, K and Thompson, PJ (2004). Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma. Journal of Allergy & Clinical Immunology, 113 (5), 889-895. doi: 10.1016/j.jaci.2004.02.008

Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma

2003

Journal Article

Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections

Yang, I. A., Seeney, S. L., Wolter, J. M., Anders, E. M., McCormack, J. G., Tunnicliffe, A. M., Rabnott, G. C., Shaw, J. G., Dent, A. G., Kim, S. T., Zimmerman, P. V. and Fong, K. M. (2003). Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections. Genes & Immunity, 4 (4), 269-274. doi: 10.1038/sj.gene.6363961

Mannose-binding lectin gene polymorphism predicts hospital admissions for COPD infections

2003

Journal Article

Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome

Child, NJA, Yang, IA, Pulletz, MCK, de Courcy-Golder, K, Andrews, AL, Pappachan, VJ and Holloway, JW (2003). Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome. Biochemical Society Transactions, 31 (3), 652-653. doi: 10.1042/BST0310652

Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome

2003

Journal Article

(-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the beta1-adrenoceptor

Sarsero, Doreen, Russell, Fraser D., Lynham, James A., Rabnott, Glenn, Yang, Ian, Fong, Kwun M., Li, Li, Kaumann, Alberto J. and Molenaar, Peter (2003). (-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the beta1-adrenoceptor. Naunyn-Schmiedeberg's Archives of Pharmacology, 367 (1), 10-21. doi: 10.1007/s00210-002-0652-9

(-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the beta1-adrenoceptor

2003

Journal Article

TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis

Yang, Ian A., Holloway, John W. and Ye, Shu (2003). TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis. Atherosclerosis, 170 (1), 187-190. doi: 10.1016/S0021-9150(03)00286-7

TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis

2002

Conference Publication

The positive inotropic effects of norepinephrine are potentiated by chronic beta1-blocker administration but are conserved across Ser49Gly- and Gly389Arg-beta1-adrenergic receptor polymorphisms in human right atrium

Molenaar, P., Russell, F. D., Rabnott, G., Yang, I., Fong, K. M., Savarimuthu, S. M., Li, L. and West, M. J. (2002). The positive inotropic effects of norepinephrine are potentiated by chronic beta1-blocker administration but are conserved across Ser49Gly- and Gly389Arg-beta1-adrenergic receptor polymorphisms in human right atrium. American Heart Association Scientific Sessions 2002, Chicago, 17-20 Nov, 2002. Hagerstown, U.S.A.: Lippincott Williams & Wilkins.

The positive inotropic effects of norepinephrine are potentiated by chronic beta1-blocker administration but are conserved across Ser49Gly- and Gly389Arg-beta1-adrenergic receptor polymorphisms in human right atrium

2002

Journal Article

Conservation of the cardiostimulant effects of (-)-Norepinephrine across Ser49Gly and Gly389Arg Beta1-adrenergic receptor polymorphisms in human right atrium in vitro

Molenaar, P., Rabnott, G., Yang, I., Fong, K. M., Savarimuthu, S. M., Li, L., West, M. J. and Russell, F. D. (2002). Conservation of the cardiostimulant effects of (-)-Norepinephrine across Ser49Gly and Gly389Arg Beta1-adrenergic receptor polymorphisms in human right atrium in vitro. Journal of The American College of Cardiology, 40 (7), 1275-1282. doi: 10.1016/S0735-1097(02)02137-X

Conservation of the cardiostimulant effects of (-)-Norepinephrine across Ser49Gly and Gly389Arg Beta1-adrenergic receptor polymorphisms in human right atrium in vitro

2002

Other Outputs

Genetic variation in COPD pathogenesis

Yang, Ian Anthony (2002). Genetic variation in COPD pathogenesis. PhD Thesis, School of Medicine, The University of Queensland. doi: 10.14264/106084

Genetic variation in COPD pathogenesis

2000

Conference Publication

Tumour necrosis factor (TNF ), myeloperoxides (MPO) and interleukin-1 receptor antagonist polymorphisms in cystic fibrosis.

Gan, R., Bowler, S. D., Seeney, S. L., Wolter, J.M., Masel, P. J., Bunting, J., Tunnicliffe, A. M., Rabnott, G. C., Yang, I. A. and Bell, S. (2000). Tumour necrosis factor (TNF ), myeloperoxides (MPO) and interleukin-1 receptor antagonist polymorphisms in cystic fibrosis.. Fourteenth Annual North American Cystic Fibrosis Conference, Baltimore Maryland, USA, 9-12 Novewmber, 2000. New York USA: Wiley-Liss.

Tumour necrosis factor (TNF ), myeloperoxides (MPO) and interleukin-1 receptor antagonist polymorphisms in cystic fibrosis.

2000

Conference Publication

Azithromycin (AZM) reduces TNF- release from lipopolysachcharide (LPS) - stimulated mononuclear cells (PBMC) in cystic fibrosis

Bell, S., Wolter, J. M., Seeney, S. L., Gan, R., Yang, I., Bowler, S. D. and Mccormack, J. G. (2000). Azithromycin (AZM) reduces TNF- release from lipopolysachcharide (LPS) - stimulated mononuclear cells (PBMC) in cystic fibrosis. Fourteenth Annual North American Cystic Fibrosis Conference, Baltimore Maryland, USA, 9-12 Novembe, 2000. New York, USA: Wiley Liss, Div John Wiley & Sons.

Azithromycin (AZM) reduces TNF- release from lipopolysachcharide (LPS) - stimulated mononuclear cells (PBMC) in cystic fibrosis

2000

Conference Publication

Azithromycin (AZM) reduced TNF- release from lipopolysachharide (LPS)-stimulated mononuclear cells (PBMC) in cystic fibrosis (CF)

Wolter, J. M., Seeney, S. L., Yang, I. A., Bowler, S. D., Bell, S. and Mccormack, J. G. (2000). Azithromycin (AZM) reduced TNF- release from lipopolysachharide (LPS)-stimulated mononuclear cells (PBMC) in cystic fibrosis (CF). ASID Annual Scientific Meeting, Laura, NSW, 15-19 April, 2001. Balgowlah NSW: ADIS Press Australia.

Azithromycin (AZM) reduced TNF- release from lipopolysachharide (LPS)-stimulated mononuclear cells (PBMC) in cystic fibrosis (CF)

1999

Conference Publication

GSTM1 and GSTT1 genotypes in Australians with NSCLC

Gan, R., Yang, I. A., Tunnicliffe, A. M., Rabnott, G. C. and Fong, K. M. (1999). GSTM1 and GSTT1 genotypes in Australians with NSCLC. Pulmonary-Renal Interface, Hyatt Regency Sanctuary Cove, 26 - 28 Nov, 1999. Qld.: Thoracic Society.

GSTM1 and GSTT1 genotypes in Australians with NSCLC

1999

Conference Publication

b2 adrenergic receptor genotypes in severe asthma

Douglas, J. A., Yang, I., Rabnott, G. C., Tunnicliffe, A. M., McCarthy, J. B., Zimmerman, P. V. and Fong, K. M. (1999). b2 adrenergic receptor genotypes in severe asthma. Heart and Lungs, Canberra, 26 Feb - 3 March 1999. Carlton, Vic.: Blackwell Science.

b2 adrenergic receptor genotypes in severe asthma

1999

Conference Publication

b2 adrenoceptor genotypes and life-threatening asthma

Rabnott, G. C., Tunnicliffe, A. M., Yang, I. A., Douglas, J. A., Shaw, J., McCarthy, J. B., Zimmerman, P. V. and Fong, K. M. (1999). b2 adrenoceptor genotypes and life-threatening asthma. Pulmonary-Renal Interface, Hyatt Regency Sanctuary Cove, 26 - 28 Nov, 1999. Qld.: Thoracic Society of Qld..

b2 adrenoceptor genotypes and life-threatening asthma

Availability

Professor Ian Yang is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Biomarkers of lung cancer

    Principal Advisor

    Other advisors: Professor Kwun Fong

  • Master Philosophy

    Elastin turnover in the lung microenvironment and its significance in Lung Repair and Non-Small Cell Lung Carcinoma (NSCLC)

    Principal Advisor

    Other advisors: Professor Kwun Fong

  • Doctor Philosophy

    Blood biomarkers for lung cancer screening

    Associate Advisor

    Other advisors: Professor Kwun Fong, Associate Professor Henry Marshall

  • Doctor Philosophy

    Randomised pragmatic trial of comprehensive tissue sampling enabled by ultrathin bronchoscopic Radial probe EndoBronchial Ultrasound versus CT-guided TransThoracic needle aspiration/biopsy (REBUTT) for evaluation of peripheral pulmonary lesions.

    Associate Advisor

    Other advisors: Professor Kwun Fong

  • Doctor Philosophy

    Precision medicine in the genomic era: emerging technologies for molecular profiling of lung cancer

    Associate Advisor

    Other advisors: Professor Kwun Fong

Completed supervision

Enquiries

For media enquiries about Professor Ian Yang's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au